Notícias e Atividades da Gain Therapeutics
Executivos
Veja o organograma con seus 15 executivos principais
Biografias mais buscadas da Gain Therapeutics
- Gene Mack, Chief Executive Officer and President
- Hans Peter Hasler, Independent Member
- Jeffrey Riley, Independent Member
Recentes movimentos de executivos em Gain Therapeutics
- Gene Mack antes Chief Financial Officer and Interim Chief Executive Officer, agora é Chief Executive Officer and President (Notícia publicada em 7 de janeiro de 2025).
- Gianluca Fuggetta antes Vice President, Finance, foi promovido a Senior Vice President Finance (Notícia publicada em 7 de janeiro de 2025).
Criar um alerta
para seguir os movimentos de executivos da Gain Therapeutics.
Biotecnologia
Gain Therapeutics possui 2.350 concorrentes concorrentes Eurofins (Luxemburgo), Lonza (Suíça) e Johnson & Johnson Innovative Medicine DIA (Estados Unidos).
Popular M&A news in Biotecnologia
- Transcarent and Accolade have merged (publicado em 9 de abril de 2025)..
- Kashiv BioSciences acaba de anunciar uma arrecadação de fundos de 150 milhões de dólares. (publicado em 7 de abril de 2025).
- Atsena Therapeutics acaba de anunciar uma arrecadação de fundos de 150 milhões de dólares. (publicado em 4 de abril de 2025).
Outros contatos sugeridos na indústria do Biotecnologia
Notícias
Últimos comunicados de imprensa de Gain Therapeutics
- Gain Therapeutics Presents Additional Preclinical Data and Design of Phase 1b Clinical Study of GT-02287 at AD/PD 2025 and Provides Enrollment Update
- Gain Therapeutics Announces Poster Presentation at AD/PD 2025
- Gain Therapeutics Reports Financial Results for the Fourth Quarter and Year End 2024 and Provides Corporate Update
- ROTH Fireside Chat with President & CEO Gene Mack
- Gain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson’s Disease
- Gain Therapeutics CEO Gene Mack Issues Letter To Shareholders and Provides Operational Update
- Gain Therapeutics To Participate in Upcoming Investor Conferences
- Gain Therapeutics Announces Formation of Clinical Advisory Board to Support Continued Advancement of Lead Drug Candidate GT-02287
- Gain Therapeutics Appoints Gene Mack as Chief Executive Officer and Director
- GT-02287 may slow Parkinson’s progression, new early data suggest
- View more press releases Close
Redes sociais sobre Gain Therapeutics
- Gain Therapeutics na Wikipedia, Google News e Yahoo Finance
- Gain Therapeutics na LinkedIn, Twitter e YouTube
